StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie cEO Pay Ratio (x:1)

DEF 14A Proxy Statement Pay Ratio & Pay vs. Performance Disclosures

Latest, FY2025
192.00
Period ended Dec 31, 2025
Change on a year earlier
+39.1%
138.00 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up ceo pay ratio (x:1)

Cite this data

StockData. (2026). AbbVie CEO Pay Ratio (x:1), annual FY2019–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/gov_ceo_pay_ratio

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.